ResearcherThe Ohio State University Wexner Medical CenterActive in the last 2 years

Taylor Neilson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-5304-2239; OpenAlex author ID A5078042635. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2025: 2 papers

Papers 2

Recurrence after neoadjuvant therapy for pancreatic cancer: same challenges, new opportunities. Co-author DOI 10.21037/hbsn-2025-96 ↗
Neoadjuvant mFOLFIRINOX for resectable pancreatic cancer: increasing evidence, ongoing challenges. Co-author DOI 10.21037/tgh-24-135 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jordan M. Cloyd · 2 shared papers, 2025 · strength 1.07
- Paper Recurrence after neoadjuvant therapy for pancreatic cancer: same challenges, new opportunities. DOI 10.21037/hbsn-2025-96 ↗
- Paper Neoadjuvant mFOLFIRINOX for resectable pancreatic cancer: increasing evidence, ongoing challenges. DOI 10.21037/tgh-24-135 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.